IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Omega Fund Management, LLC

Q3 2022 Holdings

Filed 2022-11-14 | 19 holdings | $273.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Replimune Group(REPL)Common Stock76029N106$74.1K4,288,15427.1%
Imago BiosciencesCommon Stock45250K107$45.4K3,018,73716.6%
Nuvation Bio(NUVB)Common Stock Class A67080N101$33.8K15,072,34012.4%
Cincor PharmaCommon Stock17240Y109$18.4K560,9856.7%
Gossamer Bio(GOSS)Common Stock38341P102$18.0K1,500,0006.6%
Morphic HoldingCommon Stock61775R105$16.9K597,7236.2%
Alpine Immune Sciences(NVLSEUR)Common Stock02083G100$14.6K2,029,5805.4%
Kronos Bio(KRON1USD)Common Stock50107A104$12.8K3,818,2834.7%
Ikena OncologyCommon Stock45175G108$8.0K2,249,1232.9%
Immunic Inc(IMUX)Common Stock4525EP101$5.7K1,788,1602.1%
Paratek PharmaceuticalsCommon Stock699374302$5.1K1,971,2411.9%
Sana Biotechnology, Inc.(SANA)Common Stock799566104$5.1K843,7501.9%
Omega Alpha SpacCommon Stock Class AG6749V107$5.0K501,0001.8%
Theseus PharmaceuticalsCommon Stock88369M101$4.1K711,4791.5%
Spruce BiosciencesCommon Stock85209E109$3.0K2,161,0221.1%
Syros Pharmaceuticals(SYRS)Common Stock87184Q206$1.6K251,2700.6%
Jounce Therapeutics(JNCEEUR)Common Stock481116101$645275,5130.2%
Essa Pharma(EPIEUR)Common Stock29668H708$597328,1960.2%
Senti Biosciences, Inc.Common Stock81726A100$425195,7920.2%